e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD
H. Ekroos, J. Hahl, K. Tuppurainen, K. Linden, M. Linna, H. Sintonen (Porvoo, Espoo, Helsinki, Finland)
Source:
Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Session:
Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Session type:
Thematic Poster Session
Number:
1294
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Ekroos, J. Hahl, K. Tuppurainen, K. Linden, M. Linna, H. Sintonen (Porvoo, Espoo, Helsinki, Finland). Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD. Eur Respir J 2012; 40: Suppl. 56, 1294
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Smoking cessation and COPD
Source: Eur Respir Rev 2013; 22: 37-43
Year: 2013
The cost-effectiveness of antidepressants for smoking cessation in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006
Smoking cessation strategies in patients with COPD
Source: Eur Respir J 2013; 41: 727-734
Year: 2013
The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018
Effects of smoking cessation on spirometry in mild to moderate COPD
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020
Smoking cessation and prevention
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242
Year: 2006
Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008
The effects of confrontational counselling on smoking cessation in smokers with COPD
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008
Cytisine is an effective smoking cessation medication: more evidence now than ever before
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017
Pharmacological treatment for smoking cessation on COPD smokers
Source: Annual Congress 2011 - PG19 How to set up and deliver a smoking cessation service in a pulmonology department
Year: 2011
Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007
Pharmacological treatment for smoking cessation
Source: Eur Respir Mon; 2008: 42: 74–97
Year: 2008
Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 503s
Year: 2004
Smoking cessation in asthma patients
Source: International Congress 2017 – PG14 Smoking cessation in patients with respiratory diseases
Year: 2017
Still very few smokers are prescribed smoking cessation medications
Source: ISSN=ISSN 1810-6838, ISBN=, page=172
Year: 2005
COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Recommendations for smoking cessation treatment in respiratory patients
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept